DXCM Dexcom Loading...

From PODD earnings calls
Loading chart...
Top Calls
Feed
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...
0 selected
All Content✓
Source feeds
Buzzberg Top 50 ✓
All market capsNo capitalization filter✓
200 B and aboveMega✓
10 B to 200 BLarge✓
2 B to 10 BMid✓
0 to 2 BSmall✓
Custom
Enter market cap range in B USD
All directions✓
▲ Long✓
▼ Short✓
⛔ Avoid✓
✂ Close✓
◦ Others✓
Any score✓
LOW+✓
MED+✓
HIGH✓
12:00
May 06 ◎
Ashley McEvoy CEO, Insulet Corporation PODD Q1 FY26 call
Dexcom's next-gen sensor is a key part of Insulet's integration roadmap, reinforcing their partnership.
DXCM
HIGH
13:00
Feb 18 ◎
Eric Benjamin COO, Insulet Corporation PODD Q4 FY25 call
Omnipod 5 is already compatible with Dexcom's new 15-day G7 sensor from day one, reducing risk of integration delays and preserving momentum. — This pre-emptive integration ensures no supply chain or compatibility issues that could slow Omnipod growth or sensor adoption.
DXCM
HIGH

About DXCM Analyst Coverage

Buzzberg tracks DXCM (Dexcom) across 1 sources. 0 bullish vs 0 bearish calls from 2 analysts. Sentiment: evenly split. 2 total trade ideas tracked. Latest voices: Ashley McEvoy, Eric Benjamin.